Founded in 2002, Nordic Pharma UK was one of the first European affiliate companies of the Nordic Group of companies. Over the last 16 years Nordic Pharma has worked with the NHS to supply essential and hard to obtain medicines and will continue to help the NHS meet patient needs.
Our mission within the field of haematology is to provide much needed surgical products and treatments which are both effective and well tolerated for patients within this specialist field.
Nordic Pharma works with the NHS in areas that are often outside the scope of larger pharmaceutical companies. We bring products to market that meet clear needs, for example, we licensed a novel injectable antibiotic and bought it to microbiologists and their clinical colleagues at a time when microbial resistance was becoming a significant issue. More recently in 2016 Nordic Pharma, working with the Regulatory Authority, licensed a previously withdrawn product for use in cardiac surgery; to meet a real clinical need. This is what makes Nordic Pharma different.